SCHEMBL68765

SCHEMBL68765

[CH]1C2CC3CC1CC(C2)C3

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1065540 1.00 CYP2C9 (0.32) CYP2C9
Hydrochloric Acid SCHEMBL3983262 0.96 CYP2C9 (0.30) CYP2C9
SCHEMBL2675612 0.84
SCHEMBL2674825 0.80
SCHEMBL15675078 0.74
Adamantane SCHEMBL29707714 0.71 CYP2C9 (0.46) CYP2C9
Adamantane SCHEMBL9016497 0.71 CYP2C9 (0.46) CYP2C9
Adamantane SCHEMBL12761 0.71 CYP2C9 (0.46) CYP2C9
Adamantane SCHEMBL1527414 0.71 CYP2C9 (0.46) CYP2C9
SCHEMBL176440 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11172 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197888-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2024-06-20 US claimed
US-20240190885-A1 KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX INC (US) 2024-06-13 US claimed
WO-2024112775-A1 COMPOSITIONS AND METHODS FOR EDITING A TRANSTHYRETIN GENE BEAM THERAPEUTICS INC. (US) 2024-05-30 WO claimed
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
CN-114671888-B Organic compound, organic light-emitting element, display device, photoelectric conversion device, electronic device, illumination device, and exposure light source 佳能株式会社 2024-05-03 CN claimed
US-20240131040-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2024-04-25 US claimed
US-20240124618-A1 Asymmetric Constrained Geometry Catalysts EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-04-18 US claimed
WO-2024079351-A1 NOVEL PIPERAZINE-BASED SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2024-04-18 WO claimed
US-20240115511-A1 NANOMATERIALS COMPRISING AN IONIZABLE LIPID BEAM THERAPEUTICS INC. 2024-04-11 US claimed
CN-114075180-B Immunomodulatory compounds and anti-tumor applications thereof 上海科技大学 2024-04-05 CN claimed
EP-0003007-A2 Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections Astra Läkemedel Aktiebolag (SE) 1979-07-11 EP claimed
EP-0002065-A1 Methyladamantyl hydrazines, their pharmaceutically acceptable salts and pharmaceutical compositions containing them Teva Pharmaceutical Industries Limited (IL) 1979-05-30 EP claimed
US-4112099-A FIBRINOLYTICS, THROMBOLYTICS, ANTIPHLOGISTICS, ANALGESICS CIBA-GEIGY CORPORATION (US) 1978-09-05 US claimed
US-4076822-A ANTIINFLAMMATORY AGENTS CIBA-GEIGY CORPORATION (US) 1978-02-28 US claimed
US-4064258-A Thiazole cardiovascular agents SYNTEX (U.S.A.) INC. (US) 1977-12-20 US claimed
US-4064135-A Certain thiazole-5-carboxamide compounds SYNTEX (U.S.A.) INC. (US) 1977-12-20 US claimed
US-4061746-A Lactamimide inhibitors of gastrointestinal hypersecretion RICHARDSON-MERRELL INC. (US) 1977-12-06 US claimed
US-3983123-A CNS ANTIDEPRESSANTS ENDO LABORATORIES, INC. (US) 1976-09-28 US claimed
US-3980657-A FIBRINOLYTICS, THROMBOLYTICS, ANTIPHLOGISTICS, ANALGESICS CIBA-GEIGY CORPORATION (US) 1976-09-14 US claimed
US-3968102-A VASODILATOR, ANTICOAGULANT KOHJIN CO., LTD. (JA) 1976-07-06 US claimed